Pasar al contenido principal

APROXIMACIONES NO CONVENCIONALES PARA ENTENDER Y TRATAR LAS ENFERMEDADES DE NIEMANN PICK

PID2020-112830RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

Enhanced mGluR intracellular activity causes psychiatric alterations in Niemann Pick type C disease

  • Toledano-Zaragoza, Ana
  • Enriquez-Zarralanga, Violeta
  • Naya-Forcano, Sara
  • Briz, Víctor
  • Alfaro-Ruíz, Rocío
  • Parra-Martínez, Miguel
  • Mitroi, Daniel N
  • Luján, Rafael
  • Esteban, José A
  • Ledesma, María Dolores
Niemann-Pick disease Type C (NPC) is caused by mutations in the cholesterol transport protein NPC1 leading to the endolysosomal accumulation of the lipid and to psychiatric alterations. Using an NPC mouse model (Npc1) we show aberrant mGluR lysosomal accumulation and reduction at plasma membrane in NPC1 deficient neurons. This phenotype was induced in wild-type (wt) neurons by genetic and pharmacological NPC1 silencing. Extraction of cholesterol normalized mGluR distribution in NPC1-deficient neurons. Intracellular accumulation of mGluR was functionally active leading to enhanced mGluR-dependent long-term depression (mGluR-LTD) in Npc1 hippocampal slices. mGluR-LTD was lower or higher in Npc1 slices compared with wt when stimulated with non-membrane-permeable or membrane-permeable mGluR agonists, respectively. Oral treatment with the mGluR antagonist 2-chloro-4-((2,5-dimethyl-1-(4-(trifluoromethoxy)phenyl)-1H-imidazol-4-yl)ethynyl)pyridine (CTEP) reduced mGluR-LTD and ameliorated psychiatric anomalies in the Npc1 mice. Increased neuronal mGluR levels were found in an NPC patient. These results implicate mGluR alterations in NPC psychiatric condition and provide a new therapeutic strategy that might help patients suffering from this devastating disease.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Biological relevance of Granzymes A and K during E. coli sepsis

  • Uranga Murillo, Iratxe
  • Tapia, Elena
  • Garzón, Marcela
  • Ramírez-Labrada, Ariel
  • Santiago, Llipsy
  • Pesini, Cecilia
  • Esteban, Patricia
  • Roig, Francisco J.
  • Gálvez Buerba, Eva Mª
  • Bird, Phillip I.
  • Pardo, Julián
  • Arias, Maykel
6 figures.-- Supplemenatry material available.--This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions., [Aims]: Recent in vitro findings suggest that the serine protease Granzyme K (GzmK) may act as a proinflammatory mediator. However, its role in sepsis is unknown. Here we aim to understand the role of GzmK in a mouse model of bacterial sepsis and compare it to the biological relevance of Granzyme A (GzmA)., [Methods]: Sepsis was induced in WT, GzmA-/- and GzmK-/- mice by an intraperitoneal injection of 2x108 CFU from E. coli. Mouse survival was monitored during 5 days. Levels of IL-1α, IL-1β, TNFα and IL-6 in plasma were measured and bacterial load in blood, liver and spleen was analyzed. Finally, profile of cellular expression of GzmA and GzmK was analyzed by FACS., [Results]: GzmA and GzmK are not involved in the control of bacterial infection. However, GzmA and GzmK deficient mice showed a lower sepsis score in comparison with WT mice, although only GzmA deficient mice exhibited increased survival. GzmA deficient mice also showed reduced expression of some proinflammatory cytokines like IL1-α, IL-β and IL-6. A similar result was found when extracellular GzmA was therapeutically inhibited in WT mice using serpinb6b, which improved survival and reduced IL-6 expression. Mechanistically, active extracellular GzmA induces the production of IL-6 in macrophages by a mechanism dependent on TLR4 and MyD88., [Conclusions]: These results suggest that although both proteases contribute to the clinical signs of E. coli-induced sepsis, inhibition of GzmA is sufficient to reduce inflammation and improve survival irrespectively of the presence of other inflammatory granzymes, like GzmK., This work was supported by grant SAF2017-83120-C2-1-R and PID2020-113963RBI00 from the Ministry of Science, Innovation and Universities and FEDER (Group B29_17R, Aragon Government). IU-M , MG-T and CP were supported by a PhD fellowships from Aragon Government, Ministry of Science, Innovation and Universities (FPI) and Asociacion Española contra el Cancer (AECC). MA and LS were supported by a post-doctoral fellowship “Juan de la Cierva-formación” (MA, LS) and "Juan de la Cierva-incorporacion" (MA) from the Ministry of Science, Innovation and Universities. JP was supported by ARAID Foundation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

MiR-7 controls cholesterol biosynthesis through posttranscriptional regulation of DHCR24 expression

  • Fernández-de Frutos, Mario
  • Pardo-Marqués, Virginia
  • Torrecilla-Parra, Marta
  • Rada, Patricia
  • Pérez-García, Ana
  • Martín-Martín, Yolanda
  • Peña, Gema de la
  • Gómez Peris, Ana
  • Toledano-Zaragoza, Ana
  • Gómez-Coronado, Diego
  • Casarejos, María José
  • Solís, José M.
  • Rotllan, Noemí
  • Pastor, Óscar
  • Ledesma, M. Dolores
  • Valverde, Ángela M.
  • Busto, Rebeca
  • Ramírez, Cristina M.
Dysregulation of cholesterol homeostasis is associated with several pathologies including cardiovascular diseases and neurological disorders such as Alzheimer's disease (AD). MicroRNAs (miRNAs) have emerged as key post-transcriptional regulators of cholesterol metabolism. We previously established the role of miR-7 in regulating insulin resistance and amyloidosis, which represents a common pathological feature between type 2 diabetes and AD. We show here an additional metabolic function of miR-7 in cholesterol biosynthesis. We found that miR-7 blocks the last steps of the cholesterol biosynthetic pathway in vitro by targeting relevant genes including DHCR24 and SC5D posttranscriptionally. Intracranial infusion of miR-7 on an adeno-associated viral vector reduced the expression of DHCR24 in the brain of wild-type mice, supporting in vivo miR-7 targeting. We also found that cholesterol regulates endogenous levels of miR-7 in vitro, correlating with transcriptional regulation through SREBP2 binding to its promoter region. In parallel to SREBP2 inhibition, the levels of miR-7 and hnRNPK (the host gene of miR-7) were concomitantly reduced in brain in a mouse model of Niemann Pick type C1 disease and in murine fatty liver, which are both characterized by intracellular cholesterol accumulation. Taken together, the results establish a novel regulatory feedback loop by which miR-7 modulates cholesterol homeostasis at the posttranscriptional level, an effect that could be exploited for therapeutic interventions against prevalent human diseases., This work was supported by the “Talento Program” from the Madrid Government, Spain (2017-T1/BMD-5333 and 2021-5A/BMD-20964), (RTI2018-095061-B-I00) and (PID2021-128264OB-I00) funded by MCIN/AEI/10.13039/501100011033 and “ERDF A way of making Europe” by the European Union (to CMR); Consejería de Educación e Investigación from the Madrid Government, Spain: “Convocatoria de ayudas para la contratación de ayudantes de investigación” (PEJ-2018-AI/BMD-9724) (to CMR and MT-P); “Convocatoria de ayudas para la contratación de investigadores postdoctorales” (PEDJ-2018-POST/BDM-8900) (to CMR and AP-G) and “Convocatoria de ayudas para la contratación de investigadores predoctorales” (PEJD-2019-PRE/BMD-14499) (to CMR and YM-M) from the Madrid Government, Spain; (RTI2018-098113-B-I00) (to RB and DGC) and (PID2021-122766OB-I00) (to AMV) and (PID2020-112830RB-I00) (to MD-L) funded by MCIN/AEI/10.13039/501100011033 and “ERDF A way of making Europe” by the European Union; (PI18/01152 and PI21/01173) funded by Instituto de Salud Carlos III, (ISCIII) (to OP); Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERdem), Instituto de Salud Carlos III, Madrid, Spain (research contract of P-R) and 2021-5A/BMD-20964 (research contract of VP-M). We thank the Quantification and Molecular Characterization Unit and the Lipid and Lipoprotein Unit (IRYCIS) for support., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ellagic acid and its metabolites urolithins A/B ameliorate most common disease phenotypes in cellular and mouse models for lysosomal storage disorders by enhancing extracellular vesicle secretion

  • Soto-Huelin, Beatriz
  • Babiy, Bohdan
  • Pastor, Oscar
  • Díaz-García, Mario
  • Toledano-Zaragoza, Ana
  • Frutos-Lisón, M.D.
  • Espín de Gea, Juan Carlos
  • Tomás Barberán, Francisco
  • Busto, Rebeca
  • Ledesma, M. Dolores
Niemann Pick diseases types A (NPDA) and C (NPDC) are lysosomal storage disorders (LSDs) leading to cognitive impairment, neurodegeneration, and early death. NPDA and NPDC have different genetic origins, being caused by mutations in the acid sphingomyelinase (ASM) or the cholesterol transport protein NPC1, respectively. However, they share a common pathological hallmark in the accumulation of lipids in the endolysosomal compartment. Here, we tested the hypothesis that polyphenols reduce lipid overload in NPD cells by enhancing the secretion of extracellular vesicles (ECVs). We show that among the polyphenols tested, the ellagic acid metabolites, urolithin A and B, were the safest and most efficient in increasing ECV secretion. They reduced levels of accumulating lipids and lysosomal size and permeabilization in cultured bone marrow-derived macrophages and neurons from ASMko and NPC1 mutant mice, which mimic NPDA and NPDC, respectively. Moreover, oral treatment with ellagic acid reduced lipid levels, ameliorated lysosomal alterations, and diminished microglia activation in the brain of NPD mice. These results support the therapeutic value of ECV secretion and polyphenols for NPDs, which may also help treat other LSDs characterized by intracellular lipid overload., This work was funded by grants from the Spanish Ministry of Science and Innovation (PID2020-112830RB-I00) (AEI/FEDER,UE) and the Next Generation EU-CSIC funds (NeuroAging) to M.D.L.; RTI2018-098113-B-I00 (MCIN/AEI/10.13039/501100011033) to R.B.; PI21/01173 (Instituto de Salud Carlos III, ISCIII) to O.P.; all the grants cofinanced by the European Development Regional Fund (ERDF) “A way of making Europe”. B. S–H holds a predoctoral contract (FPU) funded by the Ministerio Espanol ˜ de Ciencia e Innovacion. ´ R. B. is a researcher of the Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal, supported by Consejería de Sanidad (CAM)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sphingomyelin 16:0 is a therapeutic target for neuronal death in acid sphingomyelinase deficiency

  • Gaudioso, Ángel
  • Jiang, Xuntian
  • Casas, Josefina
  • Schuchman, Edward H.
  • Ledesma, María Dolores
Acid sphingomyelinase deficiency (ASMD) is a lysosomal storage disorder caused by mutations in the SMPD1 gene encoding for the acid sphingomyelinase (ASM). While intravenous infusion of recombinant ASM is an effective treatment for the peripheral disease, the neurological complications of ASMD remain unaddressed. It has been shown that aberrantly high level of total brain sphingomyelin (SM) is a key pathological event leading to neurodegeneration. Using mice lacking ASM (ASMko), which mimic the disease, we here demonstrate that among the SM species, SM16:0 shows the highest accumulation and toxicity in ASMko neurons. By targeting lysosomes, SM16:0 causes permeabilization and exocytosis of these organelles and induces oxidative stress and cell death. We also show that genetic silencing of Ceramide Synthase 5, which is involved in SM16:0 synthesis and overexpressed in the ASMko brain, prevents disease phenotypes in ASMko cultured neurons and mice. The levels of SM16:0 in plasma also show a strong correlation with those in brain that is higher than in liver, even at early stages of the disease. These results identify SM16:0 both as a novel therapeutic target and potential biomarker of brain pathology in ASMD., We are grateful to Steven Laffoon and the Wylder Nation Foundation (www.wyldernation.org) for the continuous support. We also thank the institutional support of the Fundación Ramón Areces to the CBMSO. This work was funded by a fellowship of the Wylder Nation Foundation to AG and by grants from the Spanish Ministry of Science and Innovation (PID2020-112830RB-I00) (AEI/FEDER,UE) and the Next Generation EU-CSIC funds (NeuroAging) to MDL.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Neurons regulate the esterification of bioactive lipid mediators in the brain of acid sphingomyelinase deficient mice

  • Taha, Ameer Y.
  • Gaudioso, Angel
  • Moran-Garrido, Maria
  • Camunas-Alberca, Sandra M
  • Bachiller-Hernandez, Jaime
  • Saiz, Jorge
  • Ledesma, Maria Dolores
  • Barbas, Coral
Acid sphingomyelinase deficiency is a neurodegenerative lysosomal storage disorder caused by mutations in the sphingomyelin-degrading enzyme acid sphingomyelinase (ASM) gene. Upregulated neuroinflammation has been well-characterized in an ASM knockout mouse model of acid sphingomyelinase deficiency disease, but lipid mediator pathways involved in ‘mediating’ inflammation and inflammation-resolution have yet to be characterized. In this study, we 1) measured free (bioactive) and esterified (inactive) lipid mediators involved in inflammation and inflammation resolution in cerebellum and neuronal cultures of ASM knockout (ASMko) mice and wildtype (WT) controls, and 2) quantified the esterification of labeled pro-resolving free d11–14(15)-epoxyeicosatrienoic acid in cultured neurons from ASMko and WT mice. We found elevated concentrations of esterified pro-resolving lipid mediators and hydroxyeicosatrienoic acids typically destined for pro-resolving lipid mediator synthesis (e.g. lipoxins) in the cerebellum and neurons of ASMko mice compared to controls. Free d11–14(15)-epoxyeicosatrienoic acid esterification within neurons of ASMko mice was significantly elevated compared to WT. Our findings show evidence of increased inactivation of free pro-resolving lipid mediators through esterification in ASMko mice, suggesting impaired resolution as a new pathway underlying ASM deficiency pathogenesis., This work was funded by a fellowship of the Wylder Nation Foundation to A.G. and by grants from the Spanish Ministry of Science and Innovation (PID2020-112830RB-I00) (AEI/FEDER,UE) and the Next Generation EU-CSIC funds (NeuroAging) to M.D.L. Additional support to A.Y.T. was provided by USDA National Institute of Food and Agriculture, Hatch/Taha (project #1008787). M.M and S.M.C. acknowledge their predoctoral fellowship from the Spanish Ministry of Universities with references FPU19/06206 and FPU21/01142 respectively., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Models to study basic and applied aspects of lysosomal storage disorders

  • Gaudioso, Ángel
  • Silva, Teresa P.
  • Ledesma, María Dolores
The lack of available treatments and fatal outcome in most lysosomal storage disorders (LSDs) have spurred research on pathological mechanisms and novel therapies in recent years. In this effort, experimental methodology in cellular and animal models have been developed, with aims to address major challenges in many LSDs such as patient-to-patient variability and brain condition. These techniques and models have advanced knowledge not only of LSDs but also for other lysosomal disorders and have provided fundamental insights into the biological roles of lysosomes. They can also serve to assess the efficacy of classical therapies and modern drug delivery systems. Here, we summarize the techniques and models used in LSD research, which include both established and recently developed in vitro methods, with general utility or specifically addressing lysosomal features. We also review animal models of LSDs together with cutting-edge technology that may reduce the need for animals in the study of these devastating diseases., This work was supported by the Spanish Ministry of Science and Innovation (PID2020-112830RB-I00) (AEI/FEDER, UE) and the NextGeneration EU-CSIC funds (NeuroAging).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Enhanced mGluR5 intracellular activity causes psychiatric alterations in Niemann Pick type C disease

  • Toledano-Zaragoza, Ana
  • Enriquez-Zarralanga, Violeta
  • Naya-Forcano, Sara
  • Briz, Víctor
  • Alfaro-Ruíz, Rocío
  • Parra-Martínez, Miguel
  • Mitroi, Daniel N.
  • Luján, Rafael
  • Esteban, José A.
  • Ledesma, María Dolores
Niemann-Pick disease Type C (NPC) is caused by mutations in the cholesterol transport protein NPC1 leading to the endolysosomal accumulation of the lipid and to psychiatric alterations. Using an NPC mouse model (Npc1) we show aberrant mGluR lysosomal accumulation and reduction at plasma membrane in NPC1 deficient neurons. This phenotype was induced in wild-type (wt) neurons by genetic and pharmacological NPC1 silencing. Extraction of cholesterol normalized mGluR distribution in NPC1-deficient neurons. Intracellular accumulation of mGluR was functionally active leading to enhanced mGluR-dependent long-term depression (mGluR-LTD) in Npc1 hippocampal slices. mGluR-LTD was lower or higher in Npc1 slices compared with wt when stimulated with non-membrane-permeable or membrane-permeable mGluR agonists, respectively. Oral treatment with the mGluR antagonist 2-chloro-4-((2,5-dimethyl-1-(4-(trifluoromethoxy)phenyl)-1H-imidazol-4-yl)ethynyl)pyridine (CTEP) reduced mGluR-LTD and ameliorated psychiatric anomalies in the Npc1 mice. Increased neuronal mGluR levels were found in an NPC patient. These results implicate mGluR alterations in NPC psychiatric condition and provide a new therapeutic strategy that might help patients suffering from this devastating disease., The authors acknowledge grants of the Spanish Ministry of Science and Innovation (PID2020-112830RB-I00 and PID2023-149557OB-I00) (AEI/FEDER,UE), of the Alicia Koplowitz Foundation and of the Next Generation EU-CSIC funds (NeuroAging) to MDL; Grant PID2021-125875OB-I00 funded by MCIN/AEI/ 10.13039/501100011033 and by “ERDF A way of making Europe” and grant from Junta de Comunidades de Castilla-La Mancha (SBPLY/21/180501/000064) to RL; and by Intertalentum Postdoctoral Program (UAM-UE), Ayuda Ramón y Cajal (RYC2021-031395-I) and Grant PID2022-136932OB-I00 to VB., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sphingomyelin-induced glucocorticoid receptor alterations lead to impaired presynaptic plasticity in acid sphingomyelinase deficient neurons

  • Naya-Forcano, Sara
  • Gaudioso, Ángel
  • Soto-Huelin, Beatriz
  • García-Vilela, Celia
  • Venero, César
  • Schuchman, Edward H.
  • Esteban, José A.
  • Ledesma, María Dolores
Acid sphingomyelinase deficiency (ASMD) is a rare disease caused by mutations in the gene encoding ASM, an enzyme that degrades sphingomyelin (SM). In addition to SM accumulation, neuroinflammation and cognitive impairment are pathological hallmarks of neurovisceral ASMD. Since the glucocorticoid system may influence these features, we have characterized it in ASM knockout (ASMko) mice that mimic this form of the disease. While plasma corticosterone levels are not altered in these mice, brain levels of the α, but not the β, isoform of glucocorticoid receptors (GR) are reduced. The reduction is evident in neurons and is due to the accumulation of SM. As a consequence, the expression of the protein, synapsin I, is low in ASMko neurons, leading to the disorganization of synaptic vesicles and to impaired presynaptic plasticity. Treatment with the glucocorticoid hydrocortisone diminished SM levels, increased synapsin I expression, and improved presynaptic function in neuronal cultures and hippocampal slices of ASMko mice. These findings establish, for the first time, a link between the glucocorticoid system and brain pathology in ASMD, highlighting the GR as a potential therapeutic target for this devastating disease., This work was funded by grants of the Spanish Ministry of Science and Innovation (PID2020-112830RB-I00 and PID2023-149557OB-I00) (AEI/FEDER, UE) to MDL and from the National Niemann Pick Disease Foundation to Sara Naya-Forcano.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sex-dependent upregulation in oxylipins involved in inflammation resolution in the cerebellum of Niemann-Pick disease C1 mice

  • Camunas-Alberca, Sandra M.
  • Moran-Garrido, Maria
  • Gaudioso, Ángel
  • da Costa Souza, Felipe
  • Gradillas, Ana
  • Ledesma, Maria Dolores
  • Barbas, Coral
  • Taha, Ameer Y.
Unresolved inflammation in the cerebellum is implicated in motor and cognitive decline in Niemann-Pick disease type C (NPC), a neurodegenerative lysosomal storage disorder caused by pathogenic mutations in the Npc1 gene encoding a cholesterol transporter protein. It is unclear whether unresolved inflammation in NPC stems from impairments in lipid-mediated resolution. For this reason, free lipid mediators (i.e., oxylipins) involved in inflammation resolution, as well as esterified lipid mediators known to regulate the bioavailability of free oxylipins were quantified using Reverse-Phase Ultra- Performance Liquid Chromatography coupled to negative Electrospray Ionization and Triple Quadrupole Tandem Mass Spectrometry (RP-UPLC-ESI(−)-QqQ-MS/MS) in Npc1 knock-in (NPC1ki) and Wildtype (WT) mice. Total cholesterol and fatty acids including polyunsaturated fatty acid (PUFA) precursors to oxylipins, were quantified using Gas Chromatography coupled to Flame Ionization Detection (GC-FID). Compared to WT mice, female NPC1ki mice, but not males, exhibited significantly elevated levels of free pro-resolving fatty acid epoxides (EpETrE and EpDPE) from the cytochrome P450 (CYP) pathway. Esterified mono- and dihydroxy lipid mediators derived from the lipoxygenase (LOX) and soluble epoxide hydrolase (sEH) pathways were mainly increased in NPC1ki females, suggesting enhanced sequestration of pro-inflammatory LOX and sEH metabolites. While PUFAs and cholesterol concentrations were not significantly different between groups, myristic (C14:0) and palmitoleic acid (C16:1n-7) were significantly elevated in female NPC1ki mice compared to WT controls. These findings suggest sex-specific adaptations in inflammation resolution pathways in NPC, with females exhibiting distinct inflammatory responses that may drive sex-related differences in disease pathogenesis. Our findings underscore the need for sex-specific therapeutic approaches to improve NPC treatment outcomes., This work was funded by a fellowship of the Wylder Nation Foundation to A.G. and by grants from the Spanish Ministry of Science and Innovation (PID2020-112830RB-I00 and PID2023-149557OB-I00) (AEI/FEDER,UE) and the Next Generation EU-CSIC funds (NeuroAging) to M.D.L. Additional support to A.Y.T. was provided by USDA National Institute of Food and Agriculture, Hatch/Taha (project #1008787).